Kansas-based Heartland Research Associates, a clinical research center and investigatory site, has completed more than 300 major vaccine studies—they have now added a COVID-19 vaccine study to their portfolio as a pharmaceutical company opted them into a trial. The...
Hammersmith Medicines Research Ltd. was scheduled to commence a trial of a potential COVID-19 vaccine when it was attacked by the Maze ransomware group on March 14, locking down its systems. When it resisted the hacking group’s demands, the latter published historic...
A local Illinois-based provider, Iroquois Memorial Hospital, has inked a collaborative partnership with a national oncology network called Cancer Treatment Centers of America (CTCA). The deal introduces not only the prospect of more advanced oncology care to the...
Spaulding Clinical Research, a West Bend, WI-based clinical research site, and a declared full-service CRO, operates a 200-bed facility while specializing in Phase I trials supporting the first-in-human clinical proof-of-concept, cardiovascular, and NDA-enabling...
hyperCORE International (hyperCORE), a growing U.S.-based integrated site network, has added two more research sites to provide additional capacity required for its growth, including AGA Clinical Trials and Clinical Site Partners. Clinical research sites compete for...
One of Europe’s leading clinical research centers, Assistance Publique – Hôpitaux de Paris (AP-HP), has joined forces with IQVIA, the global health technology, and human data science company to launch the Paris Prime Site for clinical trials. This AP-HP partnership...
